Aqueous shunts: single-plate Molteno vs ACTSEB

Area of Science:

• Ophthalmology
• Glaucoma Surgery
• Medical Device Comparison

Background:

• Refractory glaucoma management often requires surgical intervention to lower intraocular pressure (IOP).
• Glaucoma drainage devices, such as the Molteno implant and anterior chamber tube shunt, are used when conventional surgery fails.
• Both devices are constructed from silicone, a biocompatible material.

Purpose of the Study:

• To compare the efficacy and safety of single-plate Molteno implant surgery versus anterior chamber tube shunt to an encircling band procedure.
• To evaluate intraocular pressure reduction and complication rates in eyes with refractory glaucoma undergoing these surgical procedures.

Main Methods:

• A retrospective study design was employed.
• Data from 19 eyes receiving a Molteno implant and 17 eyes receiving an anterior chamber tube shunt were analyzed.
• Follow-up duration was at least 6 months, with pre- and post-operative intraocular pressure measurements recorded.

Main Results:

• Preoperative intraocular pressure was comparable between the Molteno group (47.5 +/- 11.4 mmHg) and the tube shunt group (46.5 +/- 10.3 mmHg).
• Postoperative intraocular pressure at 6 months was 20.4 +/- 15.1 mmHg for the Molteno group and 15.5 +/- 10.4 mmHg for the tube shunt group.
• The difference in IOP reduction between the two groups was not statistically significant. However, the serious complication rate within 6 months was significantly higher in the tube shunt group (47%) compared to the Molteno group (11%).

Conclusions:

• Single-plate Molteno implants and anterior chamber tube shunts offer comparable intraocular pressure reduction in refractory glaucoma.
• Molteno implants demonstrate a potentially safer profile with a lower rate of serious complications compared to anterior chamber tube shunts.
• Further investigation into surgical techniques and patient selection may be warranted to optimize outcomes for tube shunt procedures.